Surgery Partners, Inc. (SGRY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '15: 876.3M Q4 '15: 959.9M Q1 '16: 1B Q2 '16: 1.1B Q3 '16: 1.1B Q4 '16: 1.1B Q1 '17: 1.2B Q2 '17: 1.2B Q3 '18: 1.7B Q4 '18: 1.8B Q1 '19: 1.8B Q2 '19: 1.8B Q3 '19: 1.8B Q4 '19: 1.8B Q1 '20: 1.9B Q2 '20: 1.8B Q3 '20: 1.8B Q4 '20: 1.9B Q1 '21: 1.9B Q2 '21: 2.1B Q3 '21: 2.2B Q4 '21: 2.2B Q1 '22: 2.3B Q2 '22: 2.4B Q3 '22: 2.4B Q4 '22: 2.5B Q1 '23: 2.6B Q2 '23: 2.7B Q3 '23: 2.7B Q4 '23: 2.7B Q1 '24: 2.8B Q2 '24: 2.9B Q3 '24: 3B Q4 '24: 3.1B Q1 '25: 3.2B Q2 '25: 3.2B Q3 '25: 3.3B Q4 '25: 3.3B Q1 '26: 3.3B Q2 '26: 3.4B Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 300M 600M 900M Q4 '19: 423.8M Q1 '20: 407.9M Q2 '20: 358.3M Q3 '20: 373.6M Q4 '20: 379.8M Q1 '21: 408.5M Q2 '21: 471.4M Q3 '21: 479.7M Q4 '21: 491.4M Q1 '22: 512.7M Q2 '22: 529M Q3 '22: 537.7M Q4 '22: 574.9M Q1 '23: 584.1M Q2 '23: 603.6M Q3 '23: 638.2M Q4 '23: 647.5M Q1 '24: 668.8M Q2 '24: 693.9M Q3 '24: 705.6M Q4 '24: 745.6M Q1 '25: 752.2M Q2 '25: 768.6M Q3 '25: 786.4M Q4 '25: 765M Q1 '26: 763.3M Q2 '26: 757.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

0 150M 300M 450M Q4 '15: 144.8M Q1 '16: 140.7M Q2 '16: 150.6M Q3 '16: 149.2M Q4 '16: 196.5M Q1 '17: 203.9M Q2 '17: 190.7M Q3 '18: 210.1M Q4 '19: 235.9M Q1 '20: 209.8M Q2 '20: 199M Q3 '20: 158.5M Q4 '20: 183M Q1 '21: 223.8M Q2 '21: 238.6M Q3 '21: 283.7M Q4 '21: 302.2M Q1 '22: 338.3M Q2 '22: 355.3M Q3 '22: 365.8M Q4 '22: 345.2M Q1 '23: 291.2M Q2 '23: 312.3M Q3 '23: 320.8M Q4 '23: 328M Q1 '24: 357.6M Q2 '24: 344.8M Q3 '24: 323.1M Q4 '24: 348.8M Q1 '25: 334.7M Q2 '25: 361.6M Q3 '25: 406.4M Q4 '25: 389.5M Q1 '26: 393.4M Q2 '26: 383.8M Q4 '16 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-240M -160M -80M 0 80M 160M 240M Q3 '15: -69.6M Q4 '15: 1.4M Q1 '16: 1M Q2 '16: 8.5M Q3 '16: 9.3M Q4 '16: 9.5M Q1 '17: 13.9M Q2 '17: 7.3M Q3 '18: -90.2M Q4 '18: -205.7M Q1 '19: -208.3M Q2 '19: -208.6M Q3 '19: -203.3M Q4 '19: -74.8M Q1 '20: -82.2M Q2 '20: -94.9M Q3 '20: -140.8M Q4 '20: -116.1M Q1 '21: -109.6M Q2 '21: -104M Q3 '21: -65.3M Q4 '21: -70.9M Q1 '22: -37.7M Q2 '22: -29.2M Q3 '22: -31.3M Q4 '22: -54.6M Q1 '23: -91.7M Q2 '23: -54.4M Q3 '23: -34.3M Q4 '23: 35.8M Q1 '24: 48.3M Q2 '24: 13.9M Q3 '24: -12.9M Q4 '24: -168.1M Q1 '25: -193.4M Q2 '25: -180.4M Q3 '25: -171.4M Q4 '25: -77.9M Q1 '26: -76.1M Q2 '26: -88.6M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 900M 1.8B 2.7B Q3 '15: 606.7M Q4 '15: 669.3M Q1 '16: 710.3M Q2 '16: 757.5M Q3 '16: 790.1M Q4 '16: 821.2M Q1 '17: 836.4M Q2 '17: 844M Q3 '18: 1.3B Q4 '18: 1.4B Q1 '19: 1.4B Q2 '19: 1.4B Q3 '19: 1.4B Q4 '19: 1.4B Q1 '20: 1.4B Q2 '20: 1.4B Q3 '20: 1.5B Q4 '20: 1.5B Q1 '21: 1.5B Q2 '21: 1.6B Q3 '21: 1.7B Q4 '21: 1.7B Q1 '22: 1.8B Q2 '22: 1.9B Q3 '22: 1.9B Q4 '22: 2B Q1 '23: 2B Q2 '23: 2.1B Q3 '23: 2.1B Q4 '23: 2.1B Q1 '24: 2.1B Q2 '24: 2.2B Q3 '24: 2.3B Q4 '24: 2.4B Q1 '25: 2.4B Q2 '25: 2.5B Q3 '25: 2.5B Q4 '25: 2.5B Q1 '26: 2.6B Q2 '26: 2.6B Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

0 150M 300M 450M Q4 '15: 84.5M Q1 '16: 100.2M Q2 '16: 127.5M Q3 '16: 117.1M Q4 '16: 125.2M Q1 '17: 134.9M Q2 '17: 107.7M Q3 '18: 153.5M Q4 '18: 144.6M Q1 '19: 135.1M Q2 '19: 122.2M Q3 '19: 149.6M Q4 '19: 129.5M Q1 '20: 138.2M Q2 '20: 293.4M Q3 '20: 263.4M Q4 '20: 246.9M Q1 '21: 267.9M Q2 '21: 88.3M Q3 '21: 76.3M Q4 '21: 87.1M Q1 '22: 116.7M Q2 '22: 156.5M Q3 '22: 171.3M Q4 '22: 158.8M Q1 '23: 153.5M Q2 '23: 163.5M Q3 '23: 238.4M Q4 '23: 293.8M Q1 '24: 260M Q2 '24: 290.7M Q3 '24: 251.3M Q4 '24: 300.1M Q1 '25: 265.4M Q2 '25: 263.9M Q3 '25: 282.3M Q4 '25: 274.3M Q1 '26: 280M Q2 '26: 258M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 80M 160M 240M Q4 '15: 51M Q1 '16: 60.4M Q2 '16: 85.3M Q3 '16: 73.4M Q4 '16: 86.1M Q1 '17: 101.2M Q2 '17: 73.8M Q3 '18: 118M Q4 '18: 104.8M Q1 '19: 93.5M Q2 '19: 66.5M Q3 '19: 86.2M Q4 '19: 55.9M Q1 '20: 64.6M Q2 '20: 231.7M Q3 '20: 212.2M Q4 '20: 204M Q1 '21: 222.3M Q2 '21: 37.3M Q3 '21: 17.7M Q4 '21: 29.5M Q1 '22: 55.4M Q2 '22: 86.3M Q3 '22: 99.3M Q4 '22: 78.2M Q1 '23: 66.8M Q2 '23: 73.4M Q3 '23: 146.7M Q4 '23: 205M Q1 '24: 174.5M Q2 '24: 204.1M Q3 '24: 163.4M Q4 '24: 209.7M Q1 '25: 173.3M Q2 '25: 175.3M Q3 '25: 194.1M Q4 '25: 195.6M Q1 '26: 208M Q2 '26: 187.6M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q3 '14: 31.7M Q1 '15: 32.1M Q2 '15: 32.1M Q3 '15: 32.1M Q1 '16: 48M Q2 '16: 48.1M Q3 '16: 48M Q1 '17: 48M Q2 '17: 48.1M Q1 '18: 48M Q2 '18: 48M Q3 '18: 48M Q1 '19: 48M Q2 '19: 48.3M Q3 '19: 48.3M Q1 '20: 48.5M Q2 '20: 48.8M Q3 '20: 48.9M Q1 '21: 54.8M Q2 '21: 69.3M Q3 '21: 80.7M Q1 '22: 90.3M Q2 '22: 88.9M Q3 '22: 88.9M Q1 '23: 125.2M Q2 '23: 127.4M Q3 '23: 125.7M Q1 '24: 126M Q2 '24: 126.1M Q3 '24: 126.2M Q1 '25: 126.6M Q2 '25: 127M Q3 '25: 127.2M Q1 '26: 128.4M Q2 '26: 128.8M Q1 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '15: -2.17 Q4 '15: -0.13 Q1 '16: -0.07 Q2 '16: 0.14 Q3 '16: 0.19 Q4 '16: 0.19 Q1 '17: 0.28 Q2 '17: 0.15 Q3 '18: -2.54 Q4 '18: -4.96 Q1 '19: -5.03 Q2 '19: -5.05 Q3 '19: -4.95 Q4 '19: -2.29 Q1 '20: -2.45 Q2 '20: -2.72 Q3 '20: -3.67 Q4 '20: -3.18 Q1 '21: -2.99 Q2 '21: -2.52 Q3 '21: -1.34 Q4 '21: -1.12 Q1 '22: -0.41 Q2 '22: -0.23 Q3 '22: -0.23 Q4 '22: -0.59 Q1 '23: -0.93 Q2 '23: -0.57 Q3 '23: -0.33 Q4 '23: -0.09 Q1 '24: 0.01 Q2 '24: -0.26 Q3 '24: -0.47 Q4 '24: -1.33 Q1 '25: -1.53 Q2 '25: -1.43 Q3 '25: -1.36 Q4 '25: -0.61 Q1 '26: -0.59 Q2 '26: -0.69 Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.